# LETMD1

## Overview
LETMD1, or Leucine Zipper and EF-Hand Containing Transmembrane Protein 1 Domain, is a gene that encodes the LETM1 domain containing 1 protein, which is primarily localized in the mitochondria. This protein is integral to mitochondrial function, particularly in regulating mitochondrial membrane potential, reactive oxygen species (ROS) production, and ATP synthesis. LETM1 domain containing 1 is categorized as a mitochondrial protein and plays a significant role in modulating immune responses, particularly in macrophages, by controlling mitochondrial hyperpolarization and intracellular calcium levels. The gene's expression is crucial for maintaining cellular homeostasis and suppressing inflammatory responses, with its dysregulation being implicated in various pathological conditions, including cancer and metabolic disorders (Song2022Deletion; Lim2020LETMD1).

## Function
LETMD1, also known as HCCR-1, is a mitochondrial protein that plays a crucial role in regulating immune responses in macrophages. It is involved in modulating mitochondrial function, reactive oxygen species (ROS) generation, and NF-kB activation. In healthy human cells, LETMD1 negatively regulates macrophage activation by controlling mitochondrial hyperpolarization, intracellular calcium levels, and ROS production. This regulation is essential for maintaining cellular homeostasis and suppressing inflammatory activation (Lim2020LETMD1).

LETMD1 is expressed in human macrophage-like cell lines and its expression decreases following lipopolysaccharide (LPS) treatment, suggesting its role in modulating inflammatory responses. Suppression of LETMD1 leads to increased secretion of proinflammatory cytokines and enhanced phagocytic activity and migration in macrophages, indicating its function as a suppressor of LPS-induced inflammatory responses (Lim2020LETMD1).

In addition to its role in immune regulation, LETMD1 is involved in mitochondrial physiology, including membrane potential, ROS generation, and ATP synthesis. It helps maintain mitochondrial ROS production at basal levels, thus preventing excessive inflammatory activation (Lim2020LETMD1). LETMD1's function in healthy cells may involve similar regulatory mechanisms affecting mitochondrial function and immune response modulation (Lim2020LETMD1).

## Clinical Significance
LETMD1 has been implicated in various diseases due to its role in mitochondrial function and energy metabolism. Alterations in LETMD1 expression have been associated with cancer progression, particularly in cervical, breast, gastric, and colon cancers. It is known as the human cervical cancer oncogene (HCCR-1) and is involved in regulating pathways such as PI3K/Akt and P53, which are crucial in carcinogenesis (Song2022Deletion). LETMD1 is suggested as a potential early clinical diagnosis biomarker for hepatocellular carcinoma and breast cancer due to its significant role in these cancers (Song2022Deletion).

In the context of metabolic disorders, LETMD1 deletion in mice leads to severe metabolic abnormalities, including diet-induced obesity, insulin resistance, and impaired thermogenesis in brown adipose tissue (BAT) (Song2022Deletion). The gene's deletion results in mitochondrial dysfunction, which is linked to reduced expression of thermogenic genes and impaired mitochondrial dynamics, contributing to obesity and insulin resistance (Park2023Mitochondrial; Song2022Deletion). LETMD1's role in maintaining mitochondrial integrity and function in BAT suggests that mutations or dysregulation of this gene could contribute to metabolic diseases (Park2023Mitochondrial).


## References


[1. (Park2023Mitochondrial) Anna Park, Kwang-eun Kim, Isaac Park, Sang Heon Lee, Kun-Young Park, Minkyo Jung, Xiaoxu Li, Maroun Bou Sleiman, Su Jeong Lee, Dae-Soo Kim, Jaehoon Kim, Dae-Sik Lim, Eui-Jeon Woo, Eun Woo Lee, Baek Soo Han, Kyoung-Jin Oh, Sang Chul Lee, Johan Auwerx, Ji Young Mun, Hyun-Woo Rhee, Won Kon Kim, Kwang-Hee Bae, and Jae Myoung Suh. Mitochondrial matrix protein letmd1 maintains thermogenic capacity of brown adipose tissue in male mice. Nature Communications, June 2023. URL: http://dx.doi.org/10.1038/s41467-023-39106-z, doi:10.1038/s41467-023-39106-z. This article has 4 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-023-39106-z)

[2. (Song2022Deletion) Runjie Song, Yaqi Du, Peng Li, Lijun Zhou, Han Zheng, Xiaohui Lu, Shenghong Wang, Wenqiang Ma, Hua Zhang, and Xiangdong Li. Deletion of letmd1 leads to the disruption of mitochondrial function in brown adipose tissue. Biochimie, 201:100–115, October 2022. URL: http://dx.doi.org/10.1016/j.biochi.2022.07.002, doi:10.1016/j.biochi.2022.07.002. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.biochi.2022.07.002)

[3. (Lim2020LETMD1) Su-Geun Lim, Kyoungho Suk, and Won-Ha Lee. Letmd1 regulates phagocytosis and inflammatory responses to lipopolysaccharide via reactive oxygen species generation and nf-κb activation in macrophages. The Journal of Immunology, 204(5):1299–1309, March 2020. URL: http://dx.doi.org/10.4049/jimmunol.1900551, doi:10.4049/jimmunol.1900551. This article has 10 citations.](https://doi.org/10.4049/jimmunol.1900551)